yahoo_financeOriginal article
FDA Completes First-Cycle Review of Preservative-Free Ketamine ANDA with No Drug Related Major Deficiencies; Final Packaging Certification Requested for Approval
NDA FilingPreservative-Free KetaminePositive
AI Analysis
Summary
FDA completed first-cycle review of preservative-free ketamine ANDA with no drug-related major deficiencies, with final packaging certification requested as the remaining step toward approval.
Outcome Details
FDA completed first-cycle review with no drug-related major deficiencies; final packaging certification requested for approval
Importance:7/10
Sentiment:
0.70
FDA reviewANDAketaminepreservative-freeregulatory approval
Related Companies
Read the original article
Published by yahoo_finance on August 7, 2026 11:00 AM